Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention

  Influenza

  Free Subscription


Articles published in Epidemiol Infect

Retrieve available abstracts of 327 articles:
HTML format



Single Articles


    August 2023
  1. GOLDSTEIN E
    Mortality associated with Omicron and influenza infections in France before and during the COVID-19 pandemic.
    Epidemiol Infect. 2023 Aug 25:1-22. doi: 10.1017/S0950268823001358.
    PubMed    


  2. SZEKELY J, Rakchang W, Rattanaphan P, Kositpantawong N, et al
    Fluconazole and echinocandin resistance of Candida species in invasive candidiasis at a university hospital during pre-COVID-19 and the COVID-19 outbreak.
    Epidemiol Infect. 2023;151:e146.
    PubMed     Abstract available


  3. LOVE NK, Douglas A, Gharbia S, Hughes H, et al
    Understanding the impact of the COVID-19 pandemic response on GI infection surveillance trends in England, January 2020-April 2022.
    Epidemiol Infect. 2023;151:e147.
    PubMed     Abstract available


  4. JENNINGS S, Corrin T, Waddell L
    A systematic review of the evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition.
    Epidemiol Infect. 2023;151:e145.
    PubMed     Abstract available


  5. SATALA J, Wozniak A, Fabis M, Gorzelak-Pabis P, et al
    Severe COVID-19 classified by simple covid risk index is associated with higher levels of advanced oxidation protein products and 8-hydroxy 2 deoxyguanosine.
    Epidemiol Infect. 2023;151:e140.
    PubMed     Abstract available


  6. VERONESE G, Mahamid F, Bdier D
    Concerns, perceived risk, and hesitancy on COVID-19 vaccine: a qualitative exploration among university students living in the West Bank.
    Epidemiol Infect. 2023;151:e139.
    PubMed     Abstract available


    July 2023
  7. WALEKHWA AW, Nakazibwe B, Nantongo M, Wafula ST, et al
    COVID-19 second wave and clinical characteristics of cases in Uganda: A retrospective cross-sectional survey of confirmed SARS-CoV-2 cases, March-June 2021.
    Epidemiol Infect. 2023;151:e142.
    PubMed     Abstract available


  8. DE CARVALHO FS, Slack SD, Barbosa-Junior F, de Campos MR, et al
    Genomic epidemiology of SARS-CoV-2 in large university hospital cohort: the UnCoVER-Brazil project.
    Epidemiol Infect. 2023;151:e126.
    PubMed     Abstract available


  9. GERRITZEN I, Brus IM, Spronk I, Biere-Rafi S, et al
    Identification of post-COVID-19 condition phenotypes, and differences in health-related quality of life and healthcare use: a cluster analysis.
    Epidemiol Infect. 2023;151:e123.
    PubMed     Abstract available


  10. BLACKBURN AM, Han H, Gallegos A
    Cross-language validation of COVID-19 Compliance Scale in 28 languages.
    Epidemiol Infect. 2023;151:e119.
    PubMed     Abstract available


  11. ROGERS JH, Cox SN, Link AC, Nwanne G, et al
    Incidence of SARS-CoV-2 infection and associated risk factors among staff and residents at homeless shelters in King County, Washington: an active surveillance study.
    Epidemiol Infect. 2023;151:e129.
    PubMed     Abstract available


  12. HADLEY L, Karachaliou Prasinou A, Christensen H, Ramsay M, et al
    Modelling the impact of COVID-19 and routine MenACWY vaccination on meningococcal carriage and disease in the UK - ERRATUM.
    Epidemiol Infect. 2023;151:e108.
    PubMed    


  13. KULIMBET M, Saliev T, Alimbekova G, Ospanova D, et al
    Study of seroprevalence of SARS-CoV-2 in Kazakhstan.
    Epidemiol Infect. 2023;151:e116.
    PubMed     Abstract available


  14. RIEKKINEN M, Kajova M, Eriksson M, Luukkainen A, et al
    Superspreading of SARS-CoV-2 Omicron BA.2.23 among vaccinated Finnish adults: symptomatic COVID-19 only contracted by those without recent infection.
    Epidemiol Infect. 2023;151:e113.
    PubMed     Abstract available


  15. TOAN DTT, Pham TH, Nguyen KC, Pham QT, et al
    Shift from a Zero-COVID strategy to a New-normal strategy for controlling SARS-COV-2 infections in Vietnam.
    Epidemiol Infect. 2023;151:e117.
    PubMed     Abstract available


    June 2023
  16. GUO Y, Zeng X, Li L, Wang L, et al
    The impact of HBV infection on clinical outcomes of COVID-19 patients: a systematic review and meta-analysis.
    Epidemiol Infect. 2023;151:e135.
    PubMed     Abstract available


  17. LUO Y, Li Y, Xiao S, Lei H, et al
    Comparative analysis of inflight transmission of SARS-CoV-2, influenza, and SARS-CoV-1.
    Epidemiol Infect. 2023 Jun 23:1-22. doi: 10.1017/S0950268823001012.
    PubMed    


  18. RAPTI I, Asimakopoulos A, Liontos A, Kosmidou M, et al
    Association of patient characteristics with clinical outcomes in a cohort of hospitalised patients with SARS-CoV-2 infection in a Greek referral centre for COVID-19 - Corrigendum.
    Epidemiol Infect. 2023;151:e91.
    PubMed    


  19. LEOPARDI S, Desiato R, Mazzucato M, Orusa R, et al
    One health surveillance strategy for coronaviruses in Italian wildlife.
    Epidemiol Infect. 2023;151:e96.
    PubMed     Abstract available


  20. HADLEY L, Karachaliou Prasinou A, Christensen H, Ramsay M, et al
    Modelling the impact of COVID-19 and routine MenACWY vaccination on meningococcal carriage and disease in the UK.
    Epidemiol Infect. 2023;151:e98.
    PubMed     Abstract available


    May 2023
  21. HSU CY, Chen JK, Wikramaratna PS, Yen AM, et al
    Can ship travel contain COVID-19 outbreak after re-opening: a Bayesian meta-analysis.
    Epidemiol Infect. 2023;151:e99.
    PubMed     Abstract available


  22. SABIR QUA, Shafqat A, Aslam M
    Prediction of the COVID-19 transmission: a case study of Pakistan.
    Epidemiol Infect. 2023;151:e89.
    PubMed     Abstract available


  23. LUO E, Zhong Q, Wen Y, Cai J, et al
    Development and external validation of a prognostic tool for nonsevere COVID-19 inpatients.
    Epidemiol Infect. 2023;151:e128.
    PubMed     Abstract available


  24. CHANG H, Zhang X, Su H, Cai J, et al
    Epidemiological characteristics of paediatric Omicron infection during the outbreak of SARS-CoV-2 infection during March-May in 2022 in Shanghai, China.
    Epidemiol Infect. 2023;151:e81.
    PubMed     Abstract available


  25. SCHOEPS A, Walter J, Vogt M, Bent S, et al
    Direct and indirect vaccination effects on SARS-CoV-2 infection in day-care centres: Evaluating the policy for early vaccination of day-care staff in Germany, 2021.
    Epidemiol Infect. 2023;151:e80.
    PubMed     Abstract available


  26. SHI T, Huang L
    Prevalence of respiratory pathogens and risk of developing pneumonia under non-pharmaceutical interventions in Suzhou, China.
    Epidemiol Infect. 2023;151:e82.
    PubMed     Abstract available


    April 2023
  27. JOVANOVIC V, Milic M, Dotlic J, Cvjetkovic S, et al
    Mandatory and seasonal vaccination against COVID-19: Attitudes of the vaccinated people in Serbia.
    Epidemiol Infect. 2023;151:e83.
    PubMed     Abstract available


  28. FRILLI E, Amodeo D, Cevenini G, Nante N, et al
    Effectiveness of near-UVA in SARS-CoV-2 inactivation.
    Epidemiol Infect. 2023;151:e76.
    PubMed     Abstract available


  29. MERCKX J, Callies M, Kabouche I, Desombere I, et al
    SARS-CoV-2 seroprevalence and determinants for salivary seropositivity among pupils and school staff: a prospective cohort study.
    Epidemiol Infect. 2023;151:e75.
    PubMed     Abstract available


  30. WHITEHEAD J, Gan H, Heerikhuisen J, Gray G, et al
    Inequities in COVID-19 Omicron infections and hospitalisations for Maori and Pacific people in Te Manawa Taki Midland region, New Zealand.
    Epidemiol Infect. 2023;151:e74.
    PubMed     Abstract available


  31. ALHARBI B, Jennison AV, Hicks V, Whiley DM, et al
    Decreased Neisseria gonorrhoeae genotypic diversity following COVID-19 restrictions in Queensland, Australia 2020.
    Epidemiol Infect. 2023;151:e67.
    PubMed     Abstract available


  32. PRABHU VG, Hand WR, Isik T, Song Y, et al
    Risk-adjusted policies to minimise perioperative staffing shortages during a pandemic: An agent-based simulation study.
    Epidemiol Infect. 2023;151:e66.
    PubMed     Abstract available


  33. AHMED A, DeWitt ME, Dantuluri KL, Castri P, et al
    Characterisation of infection-induced SARS-CoV-2 seroprevalence amongst children and adolescents in North Carolina.
    Epidemiol Infect. 2023;151:e63.
    PubMed     Abstract available


    March 2023
  34. GOODWIN B, Zia H, Lo DF
    Assessment of early and post COVID-19 vaccination antibody response in healthcare workers: a critical review.
    Epidemiol Infect. 2023;151:e52.
    PubMed    


  35. ALLEN H, Tessier E, Turner C, Anderson C, et al
    Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England.
    Epidemiol Infect. 2023;151:e58.
    PubMed     Abstract available


  36. MIZOUE T, Yamamoto S, Oshiro Y, Inamura N, et al
    Cumulative and undiagnosed SARS-CoV-2 infection among the staff of a medical research centre in Tokyo after the emergence of variants.
    Epidemiol Infect. 2023;151:e48.
    PubMed     Abstract available


    February 2023
  37. CAPELASTEGUI F, Flannagan J, Augarde E, Tessier E, et al
    Making the invisible visible: using national surveillance data to identify people experiencing homelessness in England with COVID-19.
    Epidemiol Infect. 2023;151:e51.
    PubMed     Abstract available


  38. SALAMA M, Amitai Z, Sheffer R
    Demographic and clinical characteristics of children and adolescents hospitalised with laboratory-confirmed COVID-19 in the Tel-Aviv District, Israel, 2020-2022.
    Epidemiol Infect. 2023;151:e42.
    PubMed     Abstract available


  39. ZHOU Y, Li Z, Wu W, Xiao J, et al
    Transmission trends of the global COVID-19 pandemic with combined effects of adaptive behaviours and vaccination.
    Epidemiol Infect. 2023;151:e39.
    PubMed     Abstract available


  40. HU CY, Lei Y, Tang YW, Cui WS, et al
    Characteristics of patients with SARS-COV-2 PCR re-positivity after recovering from COVID-19.
    Epidemiol Infect. 2023;151:e34.
    PubMed     Abstract available


  41. MAIER BF, Rose AH, Burdinski A, Klamser P, et al
    Estimating the share of SARS-CoV-2-immunologically naive individuals in Germany up to June 2022.
    Epidemiol Infect. 2023;151:e38.
    PubMed     Abstract available


  42. HALL RN, Jones A, Crean E, Marriott V, et al
    Public health interventions successfully mitigated multiple incursions of SARS-CoV-2 Delta variant in the Australian Capital Territory.
    Epidemiol Infect. 2023;151:e30.
    PubMed     Abstract available


  43. TAYLOR MJ, Kumbang J, Bamford K, Mohammed Jazuli Ismail H, et al
    A SARS-CoV-2 outbreak associated with five air force bases and a nightclub following the lifting of COVID-19-related social restrictions, United Kingdom, July-to-September 2021.
    Epidemiol Infect. 2023;151:e26.
    PubMed     Abstract available


  44. IRENGE LM, Bulakali HM, Akonkwa AI, Ambroise J, et al
    Seroprevalence of COVID-19 infection in a densely populated district in the eastern Democratic Republic of Congo.
    Epidemiol Infect. 2023;151:e24.
    PubMed     Abstract available


  45. NAUTA M, McManus O, Traeholt Franck K, Lindberg Marving E, et al
    Early detection of local SARS-CoV-2 outbreaks by wastewater surveillance: a feasibility study.
    Epidemiol Infect. 2023;151:e28.
    PubMed     Abstract available


    January 2023
  46. GORI M, Fappani C, Bianchi S, Canuti M, et al
    A large A(H3N2) influenza outbreak with a high attack rate in a drug user community in Italy, April 2022.
    Epidemiol Infect. 2023 Jan 19:1-13. doi: 10.1017/S0950268823000055.
    PubMed    


  47. SALMONSMITH J, Ducci A, Balachandran R, Guo L, et al
    Use of portable air purifiers to reduce aerosols in hospital settings and cut down the clinical backlog.
    Epidemiol Infect. 2023;151:e21.
    PubMed     Abstract available


  48. ABOU HASSAN FF, Bou Hamdan M, Ali F, Melhem NM, et al
    Response to COVID-19 in Lebanon: update, challenges and lessons learned.
    Epidemiol Infect. 2023;151:e23.
    PubMed     Abstract available


  49. MANSOUR GHANAIE R, Jamee M, Khodaei H, Shirvani A, et al
    Assessment of early and post COVID-19 vaccination antibody response in healthcare workers: a multicentre cross-sectional study on inactivated, mRNA and vector-based vaccines.
    Epidemiol Infect. 2023;151:e12.
    PubMed     Abstract available


  50. GORELIK Y, Dror A, Zayyad H, Wertheim O, et al
    Associations between reported post-COVID-19 symptoms and subjective well-being, Israel, July 2021 - April 2022.
    Epidemiol Infect. 2023;151:e16.
    PubMed     Abstract available


    December 2022
  51. ROY DN, Azam MS, Biswas M, Islam E, et al
    Potential factors influencing COVID-19 vaccine acceptance and hesitancy among university students in Bangladesh: a cross-sectional comparative study.
    Epidemiol Infect. 2022;151:e11.
    PubMed     Abstract available


  52. WARD T, Glaser A, Overton CE, Carpenter B, et al
    Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
    Epidemiol Infect. 2022;151:e32.
    PubMed     Abstract available


  53. MANICA M, Litvinova M, De Bellis A, Guzzetta G, et al
    Estimation of the incubation period and generation time of SARS-CoV-2 Alpha and Delta variants from contact tracing data.
    Epidemiol Infect. 2022;151:e5.
    PubMed     Abstract available


  54. WADE D, Ashton-Butt A, Scott G, Reid SM, et al
    High pathogenicity avian influenza: Targeted active surveillance of wild birds to enable early detection of emerging disease threats.
    Epidemiol Infect. 2022 Dec 11:1-29. doi: 10.1017/S0950268822001856.
    PubMed    


  55. HOSKINS S, Beale S, Nguyen V, Boukari Y, et al
    Relative contribution of essential and non-essential activities to SARS-CoV-2 transmission following the lifting of public health restrictions in England and Wales.
    Epidemiol Infect. 2022;151:e3.
    PubMed     Abstract available


  56. GASPERINI B, Sarti D, Rondina T, Moretti M, et al
    COVID-19 isolation/quarantine rules in home care patients.
    Epidemiol Infect. 2022;150:e206.
    PubMed     Abstract available


    November 2022
  57. BHUIYAN MS, Brintz BJ, Whitcombe AL, Markmann AJ, et al
    Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection - CORRIGENDUM.
    Epidemiol Infect. 2022;150:e188.
    PubMed    


  58. PANDEY BD, Ngwe Tun MM, Pandey K, Dumre SP, et al
    Has COVID-19 suppressed dengue transmission in Nepal?
    Epidemiol Infect. 2022;150:e196.
    PubMed     Abstract available


  59. BEEBEEJAUN K, Pebody R, Ciobanu S, Pukkila J, et al
    UEFA Euro 2020: lessons from the first multi-city international mass gathering during the COVID-19 pandemic.
    Epidemiol Infect. 2022;150:e182.
    PubMed     Abstract available


  60. HEIJMINK L, Tonis J, Gilhuis N, Gerkema M, et al
    Epidemiological evaluation of mass testing in a small municipality in the Netherlands during the SARS-CoV-2 epidemic.
    Epidemiol Infect. 2022;150:e193.
    PubMed     Abstract available


  61. MIYAMA T, Jung SM, Nishiura H
    Decrease in overdispersed secondary transmission of COVID-19 over time in Japan.
    Epidemiol Infect. 2022;150:e197.
    PubMed     Abstract available


  62. MCGRATH J, McAloon CG, More SJ, Garrett S, et al
    Risk factors for SARS-CoV-2 infection in healthcare workers following an identified nosocomial COVID-19 exposure during waves 1-3 of the pandemic in Ireland.
    Epidemiol Infect. 2022;150:e186.
    PubMed     Abstract available


  63. LEE YH, Choe YJ, Lee H, Choi EH, et al
    Spatial distribution of SARS-CoV-2 infection in schools, South Korea.
    Epidemiol Infect. 2022;150:e194.
    PubMed     Abstract available


  64. LE GLASS E, Raoult D, Dubourg G
    Snapshot of COVID-19 superinfections in Marseille hospitals: where are the common pathogens?
    Epidemiol Infect. 2022;150:e195.
    PubMed     Abstract available


  65. VALLEE A
    Underestimation of the number of COVID-19 cases, an epidemiological threat.
    Epidemiol Infect. 2022;150:e191.
    PubMed    


  66. LIM WW, Cowling BJ, Nakafero G, Feng S, et al
    The impact of repeated vaccination on relative influenza vaccine effectiveness among vaccinated adults in the United Kingdom.
    Epidemiol Infect. 2022 Nov 4:1-30. doi: 10.1017/S0950268822001753.
    PubMed    


  67. BLAKEY E, Reeve L, Verlander NQ, Edwards D, et al
    Social risk factors for SARS-CoV-2 acquisition in university students: cross sectional survey.
    Epidemiol Infect. 2022;150:e201.
    PubMed     Abstract available


  68. TSUZUKI S, Akiyama T, Matsunaga N, Ohmagari N, et al
    Association between physical activity status and severity of COVID-19 in older adults.
    Epidemiol Infect. 2022;150:e189.
    PubMed     Abstract available


  69. EBERHARDT AT, Simoncini M, Pina C, Galoppo G, et al
    Preceding anti-spike IgG levels predicted risk and severity of COVID-19 during the Omicron-dominant wave in Santa Fe city, Argentina.
    Epidemiol Infect. 2022;150:e187.
    PubMed     Abstract available


    October 2022
  70. GOLDSTEIN E, Fireman BH, Klein NP, Lipsitch M, et al
    Prescribing for different antibiotic classes across age groups in the Kaiser Permanente Northern California population in association with influenza incidence, 2010-2018.
    Epidemiol Infect. 2022 Oct 26:1-30. doi: 10.1017/S0950268822001662.
    PubMed    


  71. NOMOTO H, Asai Y, Hayakawa K, Matsunaga N, et al
    Impact of the COVID-19 pandemic on racial and ethnic minorities in Japan.
    Epidemiol Infect. 2022;150:e202.
    PubMed     Abstract available


  72. FILIPPATOS F, Tatsi EB, Dellis C, Koukou DM, et al
    SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance.
    Epidemiol Infect. 2022;150:e177.
    PubMed     Abstract available


  73. MAMISHI S, Olfat M, Pourakbari B, Eshaghi H, et al
    Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in children: update and new insights from the second report of an Iranian referral hospital.
    Epidemiol Infect. 2022;150:e179.
    PubMed     Abstract available


  74. WRIGHT E, Pollard G, Robertson H, Anuradha S, et al
    Household transmission of the Delta COVID-19 variant in Queensland, Australia: a case series.
    Epidemiol Infect. 2022;150:e173.
    PubMed     Abstract available


    September 2022
  75. TAN J, Ge Y, Martinez L, Sun J, et al
    Transmission roles of symptomatic and asymptomatic COVID-19 cases: a modelling study.
    Epidemiol Infect. 2022;150:e171.
    PubMed     Abstract available


  76. ZHOU N, Dai H, Zha W, Lv Y, et al
    The impact of meteorological factors and PM2.5 on COVID-19 transmission - CORRIGENDUM.
    Epidemiol Infect. 2022;150:e164.
    PubMed    


  77. HAN H, Blackburn AM, Jeftic A, Tran TP, et al
    Validity testing of the conspiratorial thinking and anti-expert sentiment scales during the COVID-19 pandemic across 24 languages from a large-scale global dataset.
    Epidemiol Infect. 2022;150:e167.
    PubMed     Abstract available


  78. MAGAZZINO C, Mele M, Coccia M
    A machine learning algorithm to analyse the effects of vaccination on COVID-19 mortality.
    Epidemiol Infect. 2022;150:e168.
    PubMed     Abstract available


    August 2022
  79. CHEN CWS, So MKP, Liu FC
    Assessing government policies' impact on the COVID-19 pandemic and elderly deaths in East Asia.
    Epidemiol Infect. 2022;150:e161.
    PubMed     Abstract available


  80. EKROTH AKE, Patrzylas P, Turner C, Hughes GJ, et al
    Comparative symptomatology of infection with SARS-CoV-2 variants Omicron (B.1.1.529) and Delta (B.1.617.2) from routine contact tracing data in England.
    Epidemiol Infect. 2022;150:e162.
    PubMed     Abstract available


  81. BAYS D, Bennett E, Finnie T
    What effect might border screening have on preventing importation of COVID-19 compared with other infections?: considering the additional effect of post-arrival isolation.
    Epidemiol Infect. 2022;150:e159.
    PubMed     Abstract available


  82. PAGEN DME, Brinkhues S, Dukers-Muijrers NHTM, den Heijer CDJ, et al
    Sex and age differences in the proportion of experienced symptoms by SARS-CoV-2 serostatus in a community-based cross-sectional study.
    Epidemiol Infect. 2022;150:e157.
    PubMed     Abstract available


  83. BUCHHOLZ U, An der Heiden M
    Serial interval in households infected with SARS-CoV-2 variant B.1.1.529 (Omicron) are even shorter compared to Delta.
    Epidemiol Infect. 2022 Aug 5:1-5. doi: 10.1017/S0950268822001248.
    PubMed    


    July 2022
  84. NIELSEN RT, Dalby T, Emborg HD, Larsen AR, et al
    COVID-19 preventive measures coincided with a marked decline in other infectious diseases in Denmark, spring 2020.
    Epidemiol Infect. 2022;150:e138.
    PubMed     Abstract available


  85. AL-SHEHARI WA, Yin YA, Wang X, Wang Y, et al
    Prevalence and surveillance of tuberculosis in Yemen from 2006 to 2018.
    Epidemiol Infect. 2022;150:e146.
    PubMed     Abstract available


  86. SMALLMAN-RAYNOR MR, Cliff AD
    Spatial growth rate of emerging SARS-CoV-2 lineages in England, September 2020-December 2021.
    Epidemiol Infect. 2022;150:e145.
    PubMed     Abstract available


  87. PRICE O, Birrell FA, Mifsud EJ, Sullivan SG, et al
    Epidemiology of repeat influenza infection in Queensland, Australia, 2005-2017.
    Epidemiol Infect. 2022 Jul 18:1-19. doi: 10.1017/S0950268822001157.
    PubMed    


  88. SILVA MJA, Rodrigues YC, Lima KVB, Lima LNGC, et al
    Innate immunity to SARS-CoV-2 infection: a review.
    Epidemiol Infect. 2022;150:e142.
    PubMed     Abstract available


  89. IMPOUMA B, Mboussou F, Farham B, Makubalo L, et al
    COVID-19 vaccination rollout in the World Health Organization African region: status at end June 2022 and way forward.
    Epidemiol Infect. 2022;150:e143.
    PubMed     Abstract available


  90. JANNUZZI P, Panza GA
    Author response to: Letter to Editor in Response to the association between contact with children and the clinical course of COVID-19.
    Epidemiol Infect. 2022;150:e139.
    PubMed    


  91. LOSS J, Wurm J, Varnaccia G, Schienkiewitz A, et al
    Transmission of SARS-CoV-2 among children and staff in German daycare centres.
    Epidemiol Infect. 2022;150:e141.
    PubMed     Abstract available


  92. AUSTHOF E, Bell ML, Riddle MS, Catalfamo C, et al
    Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT.
    Epidemiol Infect. 2022 Jul 8:1-22. doi: 10.1017/S0950268822001200.
    PubMed    


  93. SOYEMI E, Soyemi K
    Response to the association between contact with children and the clinical course of COVID-19.
    Epidemiol Infect. 2022;150:e140.
    PubMed    


    June 2022
  94. DE MARCO VERISSIMO C, Lopez Corrales J, Dorey AL, Cwiklinski K, et al
    Production of a functionally active recombinant SARS-CoV-2 (COVID-19) 3C-like protease and a soluble inactive 3C-like protease-RBD chimeric in a prokaryotic expression system.
    Epidemiol Infect. 2022;150:e128.
    PubMed     Abstract available


  95. JUDSON SD, Torimiro J, Pigott DM, Maima A, et al
    COVID-19 data reporting systems in Africa reveal insights for future pandemics.
    Epidemiol Infect. 2022;150:e119.
    PubMed     Abstract available


  96. DEN BOOGERT EM, de Lange MMA, Wielders CCH, Rietveld A, et al
    Incidence and severity of SARS-CoV-2 infection in former Q fever patients as compared to the Dutch population, 2020-2021.
    Epidemiol Infect. 2022;150:e116.
    PubMed     Abstract available


    May 2022
  97. ADAMSON JP, Smith C, Pacchiarini N, Connor TR, et al
    A large outbreak of COVID-19 in a UK prison, October 2020 to April 2021.
    Epidemiol Infect. 2022;150:e134.
    PubMed     Abstract available


  98. RAY I, Hasan MM, Shah PA, Sahito AM, et al
    HIV epidemic amidst COVID-19 pandemic in India: a conundrum for the country's healthcare system.
    Epidemiol Infect. 2022;150:e112.
    PubMed     Abstract available


  99. XU X, Zhang K, Ma H, Shen X, et al
    Differences in service and antibiotics use following symptomatic respiratory tract infections between 2016 and 2021 in rural Anhui, China.
    Epidemiol Infect. 2022;150:e117.
    PubMed     Abstract available


  100. LACY J, Mensah A, Simmons R, Andrews N, et al
    Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England.
    Epidemiol Infect. 2022;150:e109.
    PubMed     Abstract available


  101. PARROTT JC, Annibale AM, Osahan S, Alroy K, et al
    Prevalence of SARS-CoV-2 antibodies during phased access to vaccination: results from a population-based survey in New York City, September 2020-March 2021.
    Epidemiol Infect. 2022;150:e105.
    PubMed     Abstract available


  102. EDELMAN NL, Simon P, Cassell JA, Kiss IZ, et al
    Network analysis of England's single parent household COVID-19 control policy impact: a proof-of-concept study.
    Epidemiol Infect. 2022;150:e104.
    PubMed     Abstract available


  103. LONG H, Li J, Li R, Zhang H, et al
    Plasma glucose levels and diabetes are independent predictors for mortality in patients with COVID-19.
    Epidemiol Infect. 2022;150:e106.
    PubMed     Abstract available


  104. SHINGLETON J, Finnie T, Gent N, Bennett E, et al
    Assessing the role of imported cases on the establishment of SARS-CoV-2 Delta variant of concern in Bolton, UK.
    Epidemiol Infect. 2022;150:e100.
    PubMed     Abstract available


  105. HIIRONEN I, Saavedra-Campos M, Panitz J, Ma T, et al
    Workplace exposures associated with COVID-19: evidence from a case-control study with multiple sampling periods in England, August-October 2020.
    Epidemiol Infect. 2022;150:e99.
    PubMed     Abstract available


  106. THOMAS DR, Fina LH, Adamson JP, Sawyer C, et al
    Social, demographic and behavioural determinants of SARS-CoV-2 infection: a case-control study carried out during mass community testing of asymptomatic individuals in South Wales, December 2020.
    Epidemiol Infect. 2022;150:e115.
    PubMed     Abstract available


  107. POKUTNAYA D, Loiacono MM, Booth H, Williams R, et al
    The impact of clinical risk conditions on influenza and pneumonia diagnoses in England: a nationally-representative retrospective cohort study, 2010-2019.
    Epidemiol Infect. 2022 May 6:1-24. doi: 10.1017/S0950268822000838.
    PubMed    


    April 2022
  108. WONG JY, Cheung CM, Bond HS, Cheung JK, et al
    Estimating excess septicaemia mortality and hospitalisation burden associated with influenza in Hong Kong, 1998 to 2019.
    Epidemiol Infect. 2022;150:e101.
    PubMed     Abstract available


  109. FABRICIUS G, Borzi RA, Caminos J, Grigera TS, et al
    Immunity acquired by a minority active fraction of the population could explain COVID-19 spread in Greater Buenos Aires (June-November 2020).
    Epidemiol Infect. 2022;150:e84.
    PubMed     Abstract available


  110. RICCARDO F, Frisicale EM, Guzzetta G, Ferraro F, et al
    Winning during a pandemic: epidemiology of SARS-CoV-2 during EURO2020 in Italy.
    Epidemiol Infect. 2022;150:e166.
    PubMed     Abstract available


    March 2022
  111. SCHULMAN A, Bhanot G
    Using postal change-of-address data to predict second waves in infections near pandemic epicentres.
    Epidemiol Infect. 2022;150:e120.
    PubMed     Abstract available


  112. BENNEDBAEK M, Button MSF, Nielsen LB, Bybjerg-Grauholm J, et al
    Increased transmission of SARS-CoV-2 in Denmark during UEFA European championships.
    Epidemiol Infect. 2022;150:e123.
    PubMed     Abstract available


  113. SARVIKIVI E, Salminen M, Savolainen-Kopra C, Ikonen N, et al
    COVID-19 cases in spectators returning to Finland from UEFA Euro 2020 matches in Saint Petersburg.
    Epidemiol Infect. 2022;150:e121.
    PubMed     Abstract available


  114. DASH P, Mansingh A, Nayak SR, Sahoo D, et al
    Infection, cases due to SARS-CoV-2 in rural areas during early COVID-19 vaccination: findings from serosurvey study in a rural cohort of eastern India.
    Epidemiol Infect. 2022;150:e58.
    PubMed     Abstract available


  115. HUANG Z, Guo H, Lim HY, Chow A, et al
    Determinants of the acceptance and adoption of a digital contact tracing tool during the COVID-19 pandemic in Singapore.
    Epidemiol Infect. 2022;150:e54.
    PubMed     Abstract available


    February 2022
  116. GOLDSTEIN E, Fireman BH, Klein NP, Lipsitch M, et al
    Antibiotic prescribing across age groups in the Kaiser Permanente Northern California population in association with different diagnoses, and with influenza incidence, 2010-2018.
    Epidemiol Infect. 2022;150:e85.
    PubMed     Abstract available


  117. AWAN HA, Sahito AM, Sukaina M, Khatri G, et al
    Tuberculosis amidst COVID-19 in Pakistan: a massive threat of overlapping crises for the fragile healthcare systems.
    Epidemiol Infect. 2022;150:e41.
    PubMed     Abstract available


  118. PECKEU-ABBOUD L, van Kleef E, Smekens T, Latour K, et al
    Factors influencing SARS-CoV-2 infection rate in Belgian nursing home residents during the first wave of COVID-19 pandemic.
    Epidemiol Infect. 2022;150:e72.
    PubMed     Abstract available


  119. YUN KW, Kim YK, Song ES, An HY, et al
    Outbreak of COVID-19 among children and young adults in a cancer centre daycare unit.
    Epidemiol Infect. 2022;150:e40.
    PubMed     Abstract available


  120. CORDIOLI M, Mirandola M, Gios L, Gaspari S, et al
    COVID-19 seroprevalence amongst healthcare workers: potential biases in estimating infection prevalence.
    Epidemiol Infect. 2022;150:e48.
    PubMed     Abstract available


  121. HEINZINGER S, Eberle U, Angermeier H, Flechsler J, et al
    Reciprocal circulation pattern of SARS-CoV-2 and influenza viruses during the influenza seasons 2019/2020 and 2020/2021 in the Bavarian Influenza Sentinel (Germany) - CORRIGENDUM.
    Epidemiol Infect. 2022;150:e24.
    PubMed    


  122. BROOKES SM, Mansfield KL, Reid SM, Coward V, et al
    Incursion of H5N8 High Pathogenicity Avian Influenza Virus (HPAIV) into Gamebirds in England.
    Epidemiol Infect. 2022 Feb 10:1-36. doi: 10.1017/S0950268821002740.
    PubMed    


  123. POMEROY MA, Hoover ER, Dumas BL, Kennedy KS, et al
    Decisions to attend holiday gatherings during COVID-19 and engagement in key prevention strategies: United States, January 2021.
    Epidemiol Infect. 2022;150:e32.
    PubMed     Abstract available


  124. SEVINC SA, Metin S, Basi NB, Ling J, et al
    Effectiveness of inactivated SARS-CoV-2 vaccine (CoronaVac) on intensive care unit survival.
    Epidemiol Infect. 2022;150:e35.
    PubMed     Abstract available


  125. HAN H
    Trust in the scientific research community predicts intent to comply with COVID-19 prevention measures: An analysis of a large-scale international survey dataset.
    Epidemiol Infect. 2022;150:e36.
    PubMed     Abstract available


  126. NA'AMNIH W, Kassem E, Tannous S, Kagan V, et al
    Incidence and risk factors of hospitalisations for respiratory syncytial virus among children aged less than 2 years.
    Epidemiol Infect. 2022;150:e45.
    PubMed     Abstract available


    January 2022
  127. SMITH JAE, Hopkins S, Turner C, Dack K, et al
    Public health impact of mass sporting and cultural events in a rising COVID-19 prevalence in England.
    Epidemiol Infect. 2022;150:e42.
    PubMed     Abstract available


  128. KASSIE A, Handebo S, Adugna A, Shitu K, et al
    Violence against girls during COVID-19 pandemic and associated factors in Gondar city, North West Ethiopia.
    Epidemiol Infect. 2022;150:e31.
    PubMed     Abstract available


  129. LIU F, Zhao Z, Ma C, Nie X, et al
    Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants.
    Epidemiol Infect. 2022;150:e46.
    PubMed     Abstract available


  130. ZHOU N, Dai H, Zha W, Lv Y, et al
    The impact of meteorological factors and PM2.5 on COVID-19 transmission.
    Epidemiol Infect. 2022;150:e38.
    PubMed     Abstract available


  131. SPAHN C, Hipp AM, Richter B, Nusseck M, et al
    Coronavirus vaccination rates in cultural areas in Germany.
    Epidemiol Infect. 2022;150:e34.
    PubMed     Abstract available


  132. DECUIR J, Baggs J, Melgar M, Patel P, et al
    Identification and description of patients with multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection using the Premier Healthcare Database.
    Epidemiol Infect. 2022;150:e26.
    PubMed     Abstract available


  133. ESKILD A, Morkrid L, Mortensen SB, Leegaard TM, et al
    Prevalence of antibodies against SARS-CoV-2 among pregnant women in Norway during the period December 2019 through December 2020.
    Epidemiol Infect. 2022;150:e28.
    PubMed     Abstract available


  134. LIM C, Nam Y, Oh WS, Ham S, et al
    Characteristics of transmission routes of COVID-19 cluster infections in Gangwon Province, Korea.
    Epidemiol Infect. 2022;150:e19.
    PubMed     Abstract available


  135. BHUIYAN MS, Brintz BJ, Whitcombe AL, Markmann AJ, et al
    Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection.
    Epidemiol Infect. 2022;150:e20.
    PubMed     Abstract available


  136. CAVANY S, Bivins A, Wu Z, North D, et al
    Inferring SARS-CoV-2 RNA shedding into wastewater relative to the time of infection.
    Epidemiol Infect. 2022;150:e21.
    PubMed     Abstract available


    December 2021
  137. NOAH N, Edelstein M
    African COVID-19 special issue introduction.
    Epidemiol Infect. 2021;149:e257.
    PubMed    


  138. SCHOOLING CM, Li M, Au Yeung SL
    Interleukin-18 and COVID-19.
    Epidemiol Infect. 2021;150:e14.
    PubMed     Abstract available


  139. TSUZUKI S, Ohmagari N, Beutels P
    The burden of isolation to the individual: a comparison between isolation for COVID-19 and for other influenza-like illnesses in Japan.
    Epidemiol Infect. 2021;150:e5.
    PubMed     Abstract available


  140. MUGHINI-GRAS L, Chaname Pinedo L, Pijnacker R, van den Beld M, et al
    Impact of the COVID-19 pandemic on human salmonellosis in the Netherlands.
    Epidemiol Infect. 2021;149:e254.
    PubMed     Abstract available


    November 2021
  141. ALJOHANI NI, Mutai K
    Effect of non-pharmacological interventions on the COVID-19 epidemic in Saudi Arabia.
    Epidemiol Infect. 2021;149:e252.
    PubMed     Abstract available


  142. MUNCH PK, Espenhain L, Hansen CH, Muller L, et al
    Societal activities associated with SARS-CoV-2 infection: a case-control study in Denmark, November 2020.
    Epidemiol Infect. 2021;150:e9.
    PubMed     Abstract available


  143. MAGAZZINO C, Mele M, Schneider N
    Assessing a fossil fuels externality with a new neural networks and image optimisation algorithm: the case of atmospheric pollutants as confounders to COVID-19 lethality.
    Epidemiol Infect. 2021;150:e1.
    PubMed     Abstract available


  144. LAI J, Hughes HE, Morbey R, Loveridge P, et al
    Developing a sentinel syndromic surveillance system using school-absenteeism data, example monitoring absences over the 2020 COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e248.
    PubMed     Abstract available


  145. TATSI EB, Filippatos F, Michos A
    SARS-CoV-2 variants and effectiveness of vaccines: a review of current evidence.
    Epidemiol Infect. 2021;149:e237.
    PubMed     Abstract available


  146. BAYS D, Bennett E, Finnie T
    What effect might border screening have on preventing the importation of COVID-19 compared with other infections? A modelling study.
    Epidemiol Infect. 2021;149:e238.
    PubMed     Abstract available


  147. IMPOUMA B, Mboussou F, Shahpar C, Wolfe CM, et al
    Estimating the SARS-CoV2 infections detection rate and cumulative incidence in the World Health Organization African Region 10 months into the pandemic.
    Epidemiol Infect. 2021;149:e264.
    PubMed     Abstract available


  148. IMPOUMA B, Mboussou F, Farham B, Wolfe CM, et al
    The COVID-19 pandemic in the WHO African region: the first year (February 2020 to February 2021).
    Epidemiol Infect. 2021;149:e263.
    PubMed     Abstract available


  149. LI R, Li Q, Liu Y, Shen M, et al
    Modelling the impact of universal influenza vaccines on seasonal influenza with different subtypes.
    Epidemiol Infect. 2021;149:e253.
    PubMed     Abstract available


    October 2021
  150. NICHOLS M, Gollarza L, Palacios A, Stapleton GS, et al
    Salmonella illness outbreaks linked to backyard poultry purchasing during the COVID-19 pandemic: United States, 2020.
    Epidemiol Infect. 2021;149:e234.
    PubMed     Abstract available


  151. JUUTINEN A, Sarvikivi E, Laukkanen-Nevala P, Helve O, et al
    Closing lower secondary schools had no impact on COVID-19 incidence in 13-15-year-olds in Finland.
    Epidemiol Infect. 2021;149:e233.
    PubMed     Abstract available


  152. HEINZINGER S, Eberle U, Angermeier H, Flechsler J, et al
    Reciprocal circulation pattern of SARS-CoV-2 and influenza viruses during the influenza seasons 2019/2020 and 2020/2021 in the Bavarian Influenza Sentinel (Germany).
    Epidemiol Infect. 2021;149:e226.
    PubMed     Abstract available


  153. MANCILLA-GALINDO J, Kammar-Garcia A, Martinez-Esteban A, Meza-Comparan HD, et al
    COVID-19 patients with increasing age experience differential time to initial medical care and severity of symptoms.
    Epidemiol Infect. 2021;149:e230.
    PubMed     Abstract available


  154. GONZALEZ F, Vielot NA, Sciaudone M, Toval-Ruiz C, et al
    Seroepidemiology of SARS-CoV-2 infections in an urban population-based cohort in Leon, Nicaragua.
    Epidemiol Infect. 2021;149:e247.
    PubMed     Abstract available


  155. AEMRO A, Amare NS, Shetie B, Chekol B, et al
    Determinants of COVID-19 vaccine hesitancy among health care workers in Amhara region referral hospitals, Northwest Ethiopia: a cross-sectional study.
    Epidemiol Infect. 2021;149:e225.
    PubMed     Abstract available


  156. SINGH C, Naik BN, Pandey S, Biswas B, et al
    Effectiveness of COVID-19 vaccine in preventing infection and disease severity: a case-control study from an Eastern State of India.
    Epidemiol Infect. 2021;149:e224.
    PubMed     Abstract available


  157. ZHAO X, Shen Z, Sun L, Cheng L, et al
    A network meta-analysis of secondary attack rates of COVID-19 in different contact environments.
    Epidemiol Infect. 2021;149:e219.
    PubMed     Abstract available


    September 2021
  158. KEITA MB, Pierre F, Ndjomou J, Traore B, et al
    The first epidemiological and virological influenza surveillance in the Republic of Guinea revealed the predominance of influenza A/H3N2 and B Victoria viruses.
    Epidemiol Infect. 2021 Sep 28:1-20. doi: 10.1017/S0950268821001965.
    PubMed    


  159. SCHOEPS A, Hoffmann D, Tamm C, Vollmer B, et al
    Surveillance of SARS-CoV-2 transmission in educational institutions, August to December 2020, Germany.
    Epidemiol Infect. 2021;149:e213.
    PubMed     Abstract available


  160. CHENG X, Li Y, Zhang Y, Lu J, et al
    The characteristics of and responses to the two COVID-19 outbreak waves in Hebei Province of China, January 2020 to February 2021.
    Epidemiol Infect. 2021;149:e212.
    PubMed     Abstract available


  161. AKTAS YILDIRIM S, Sarikaya ZT, Ulugol H, Ozata S, et al
    Are surgical and non-operating room intervention safe in the COVID-19 pandemic? A retrospective study.
    Epidemiol Infect. 2021;149:e210.
    PubMed     Abstract available


  162. GOLDENFELD M, Zuckerman N, Amit S, Tal I, et al
    First reported nosocomial SARS-CoV-2 outbreak in a hospital-based laundry facility.
    Epidemiol Infect. 2021;150:e18.
    PubMed     Abstract available


  163. MUSA OAH, Chivese T, Bansal D, Abdulmajeed J, et al
    Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.
    Epidemiol Infect. 2021;149:e203.
    PubMed    


  164. SPINICCI M, Pengue L, Bartolozzi D, Quercioli M, et al
    Soccer in the time of COVID-19: 1 year report from an Italian top league club, March 2020-February 2021.
    Epidemiol Infect. 2021;149:e207.
    PubMed     Abstract available


  165. IMPOUMA B, Williams GS, Moussana F, Mboussou F, et al
    The first 8 months of COVID-19 pandemic in three West African countries: leveraging lessons learned from responses to the 2014-2016 Ebola virus disease outbreak.
    Epidemiol Infect. 2021;149:e258.
    PubMed     Abstract available


    August 2021
  166. ABU JABAL K, Ben-Amram H, Beiruti K, Brimat I, et al
    SARS-CoV-2 immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021.
    Epidemiol Infect. 2021;149:e239.
    PubMed     Abstract available


  167. MBOUSSOU F, Impouma B, Farham B, Wolfe CM, et al
    Analysing the reported incidence of COVID-19 and factors associated in the World Health Organization African region as of 31 December 2020.
    Epidemiol Infect. 2021;149:e256.
    PubMed     Abstract available


  168. ALPCAN A, Tursun S, Kandur Y
    Vitamin D levels in children with COVID-19: a report from Turkey.
    Epidemiol Infect. 2021;149:e180.
    PubMed     Abstract available


  169. NAESENS R, Mertes H, Clukers J, Herzog S, et al
    SARS-CoV-2 seroprevalence survey among health care providers in a Belgian public multiple-site hospital.
    Epidemiol Infect. 2021;149:e172.
    PubMed     Abstract available


  170. BAUMEISTER A, Corrin T, Abid H, Young KM, et al
    The quality of systematic reviews and other synthesis in the time of COVID-19.
    Epidemiol Infect. 2021;149:e182.
    PubMed     Abstract available


  171. CHENG CH, Chow CL, Chow WK
    A discussion on the minimum required number of tests in two common pooling test methods for SARS-CoV-2.
    Epidemiol Infect. 2021;149:e179.
    PubMed     Abstract available


  172. MELOTTI R, Scaggiante F, Falciani M, Weichenberger CX, et al
    Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena valley.
    Epidemiol Infect. 2021;149:e194.
    PubMed     Abstract available


  173. KELLY G, Petti S, Noah N
    Covid-19, non-Covid-19 and excess mortality rates not comparable across countries.
    Epidemiol Infect. 2021;149:e176.
    PubMed     Abstract available


  174. ALVES JD, Abade AS, Peres WP, Borges JE, et al
    Impact of COVID-19 on the indigenous population of Brazil: a geo-epidemiological study.
    Epidemiol Infect. 2021;149:e185.
    PubMed     Abstract available


    July 2021
  175. OTTAVIANO E, Parodi C, Borghi E, Massa V, et al
    Saliva detection of SARS-CoV-2 for mitigating company outbreaks: a surveillance experience, Milan, Italy, March 2021.
    Epidemiol Infect. 2021;149:e171.
    PubMed     Abstract available


  176. YI B, Poetsch AR, Stadtmuller M, Rost F, et al
    Phylogenetic analysis of SARS-CoV-2 lineage development across the first and second waves in Eastern Germany in 2020: insights into the cause of the second wave.
    Epidemiol Infect. 2021;149:e177.
    PubMed     Abstract available


  177. CARLTON LH, Chen T, Whitcombe AL, McGregor R, et al
    Charting elimination in the pandemic: a SARS-CoV-2 serosurvey of blood donors in New Zealand.
    Epidemiol Infect. 2021;149:e173.
    PubMed     Abstract available


  178. YAMADA G, Hayakawa K, Matsunaga N, Terada M, et al
    Predicting respiratory failure for COVID-19 patients in Japan: a simple clinical score for evaluating the need for hospitalisation.
    Epidemiol Infect. 2021;149:e175.
    PubMed     Abstract available


  179. BREWER TF, Zhang M, Gordon D, Chung RY, et al
    Housing, sanitation and living conditions affecting SARS-CoV-2 prevention interventions in 54 African countries.
    Epidemiol Infect. 2021;149:e183.
    PubMed     Abstract available


  180. YAKOB L
    Isolation thresholds for curbing SARS-CoV-2 resurgence.
    Epidemiol Infect. 2021;149:e168.
    PubMed     Abstract available


  181. THOMAS BS, Marks NA
    Estimating the case fatality ratio for COVID-19 using a time-shifted distribution analysis.
    Epidemiol Infect. 2021;149:e197.
    PubMed     Abstract available


  182. BOENDER TS, Bender JK, Kruger A, Michaelis K, et al
    Factors preventing SARS-CoV-2 transmission during unintentional exposure in a GP practice: a cohort study of patient contacts; Germany, 2020.
    Epidemiol Infect. 2021;149:e161.
    PubMed     Abstract available


  183. AKHMETZHANOV AR
    Estimation of delay-adjusted all-cause excess mortality in the USA: March-December 2020.
    Epidemiol Infect. 2021;149:e156.
    PubMed     Abstract available


  184. DITE GS, Murphy NM, Allman R
    Development and validation of a clinical and genetic model for predicting risk of severe COVID-19.
    Epidemiol Infect. 2021;149:e162.
    PubMed     Abstract available


  185. MUSA OAH, Chivese T, Bansal D, Abdulmajeed J, et al
    Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.
    Epidemiol Infect. 2021;149:e193.
    PubMed     Abstract available


    June 2021
  186. CARDENAS VM
    RE: George et al. 'High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?'
    Epidemiol Infect. 2021;149:e151.
    PubMed    


  187. GEORGE CE, Inbaraj LR
    Re: George et al. High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?
    Epidemiol Infect. 2021;149:e152.
    PubMed    


  188. GOZLAN Y, Reingold S, Koren R, Halpern O, et al
    SARS-CoV-2 outbreak in a synagogue community: longevity and strength of anti-SARS-CoV-2 IgG responses.
    Epidemiol Infect. 2021;149:e153.
    PubMed     Abstract available


  189. WOUDENBERG T, Eberle U, Marosevic D, Liebl B, et al
    Detection and viral RNA shedding of SARS-CoV-2 in respiratory specimens relative to symptom onset among COVID-19 patients in Bavaria, Germany.
    Epidemiol Infect. 2021;149:e150.
    PubMed     Abstract available


  190. ZHANG R, Gao Y, Xie D, Lian R, et al
    Characteristics of systematic reviews evaluating treatments for COVID-19 registered in PROSPERO.
    Epidemiol Infect. 2021;149:e146.
    PubMed     Abstract available


  191. MALDONADO MD, Romero-Aibar J, Perez-San-Gregorio MA
    COVID-19 pandemic as a risk factor for the reactivation of herpes viruses.
    Epidemiol Infect. 2021;149:e145.
    PubMed     Abstract available


  192. DE MARCO VERISSIMO C, O'Brien C, Lopez Corrales J, Dorey A, et al
    Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests.
    Epidemiol Infect. 2021;149:e140.
    PubMed     Abstract available


  193. GUVEN BB, Erturk T, Kompe O, Ersoy A, et al
    Serious complications in COVID-19 ARDS cases: pneumothorax, pneumomediastinum, subcutaneous emphysema and haemothorax.
    Epidemiol Infect. 2021;149:e137.
    PubMed     Abstract available


    May 2021
  194. IMPOUMA B, Mlanda T, Bukhari A, Sie Williams G, et al
    Information management practices in the WHO African Region to support response to the COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e260.
    PubMed     Abstract available


  195. JAIN J, Saurabh S, Kumar P, Verma MK, et al
    COVID-19 vaccine hesitancy among medical students in India.
    Epidemiol Infect. 2021;149:e132.
    PubMed     Abstract available


  196. MCDONALD SA, van den Wijngaard CC, Wielders CCH, Friesema IHM, et al
    Risk factors associated with the incidence of self-reported COVID-19-like illness: data from a web-based syndromic surveillance system in the Netherlands.
    Epidemiol Infect. 2021;149:e129.
    PubMed     Abstract available


  197. DE SOUZA ARAUJO AA, Quintans-Junior LJ, Heimfarth L, Schimieguel DM, et al
    Seroprevalence of SARS-CoV-2 antibodies in the poorest region of Brazil: results from a population-based study.
    Epidemiol Infect. 2021;149:e130.
    PubMed     Abstract available


  198. HAMMER CC, Cristea V, Dub T, Sivela J, et al
    High but slightly declining COVID-19 vaccine acceptance and reasons for vaccine acceptance, Finland April to December 2020.
    Epidemiol Infect. 2021;149:e123.
    PubMed     Abstract available


  199. IMPOUMA B, Mboussou F, Wolfe CM, Farham B, et al
    COVID-19 in the WHO African region: using risk assessment to inform decisions on public health and social measures.
    Epidemiol Infect. 2021;149:e259.
    PubMed     Abstract available


    April 2021
  200. MAJUMDAR P, Niyogi S
    SARS-CoV-2 mutations: the biological trackway towards viral fitness.
    Epidemiol Infect. 2021;149:e110.
    PubMed     Abstract available


  201. CRUZ EHM, Maciel JM, Clozato CL, Serpa MS, et al
    Simulation-based evaluation of school reopening strategies during COVID-19: A case study of Sao Paulo, Brazil.
    Epidemiol Infect. 2021;149:e118.
    PubMed     Abstract available


  202. ZHAO S, Yang Z, Musa SS, Ran J, et al
    Attach importance of the bootstrap t test against Student's t test in clinical epidemiology: a demonstrative comparison using COVID-19 as an example.
    Epidemiol Infect. 2021;149:e107.
    PubMed     Abstract available


  203. VERA-ZERTUCHE JM, Mancilla-Galindo J, Tlalpa-Prisco M, Aguilar-Alonso P, et al
    Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study.
    Epidemiol Infect. 2021;149:e109.
    PubMed     Abstract available


  204. MOUSSA R, Majdalani S
    Use of the Hayami diffusive wave equation to model the relationship infected-recoveries-deaths of Covid-19 pandemic.
    Epidemiol Infect. 2021;149:e138.
    PubMed     Abstract available


  205. SHARIF N, Ahmed SN, Opu RR, Daullah MU, et al
    Impact of meteorological parameters and population density on variants of SARS-CoV-2 and outcome of COVID-19 pandemic in Japan.
    Epidemiol Infect. 2021;149:e103.
    PubMed     Abstract available


  206. KIM SH, Kim YJ, Jeong YJ, Park JH, et al
    Construction of a non-contact community treatment centre for asymptomatic and mildly symptomatic COVID-19 patients during the COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e111.
    PubMed     Abstract available


  207. LOPEZ-CHEDA A, Jacome MA, Cao R, De Salazar PM, et al
    Estimating lengths-of-stay of hospitalised COVID-19 patients using a non-parametric model: a case study in Galicia (Spain).
    Epidemiol Infect. 2021;149:e102.
    PubMed     Abstract available


  208. KSHATRI JS, Bhattacharya D, Praharaj I, Mansingh A, et al
    Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys.
    Epidemiol Infect. 2021;149:e139.
    PubMed     Abstract available


  209. ALLEN N, Riain UN, Conlon N, Ferenczi A, et al
    Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
    Epidemiol Infect. 2021;149:e157.
    PubMed     Abstract available


  210. DRESSLER A, Finci I, Wagner-Wiening C, Eichner M, et al
    Epidemiological analysis of 3,219 COVID-19 outbreaks in the state of Baden-Wuerttemberg, Germany.
    Epidemiol Infect. 2021;149:e101.
    PubMed     Abstract available


  211. BAGGIO JAO, Machado MF, Carmo RFD, Armstrong ADC, et al
    COVID-19 in Brazil: spatial risk, social vulnerability, human development, clinical manifestations and predictors of mortality - a retrospective study with data from 59 695 individuals.
    Epidemiol Infect. 2021;149:e100.
    PubMed     Abstract available


  212. LUO S, Xin M, Wang S, Zhao J, et al
    Behavioural intention of receiving COVID-19 vaccination, social media exposures and peer discussions in China.
    Epidemiol Infect. 2021;149:e158.
    PubMed     Abstract available


  213. ZARE F, Teimouri M, Khosravi A, Rohani-Rasaf M, et al
    COVID-19 re-infection in Shahroud, Iran: a follow-up study.
    Epidemiol Infect. 2021;149:e159.
    PubMed     Abstract available


  214. MARCO A, Gallego C, Perez-Caceres V, Guerrero RA, et al
    Public health response to an outbreak of SARS-CoV2 infection in a Barcelona prison.
    Epidemiol Infect. 2021;149:e91.
    PubMed     Abstract available


  215. KARIMZADEH S, Bhopal R, Nguyen Tien H
    Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses.
    Epidemiol Infect. 2021;149:e96.
    PubMed     Abstract available


  216. IMPOUMA B, Wolfe CM, Mboussou F, Farham B, et al
    Monitoring and evaluation of COVID-19 response in the WHO African region: challenges and lessons learned.
    Epidemiol Infect. 2021;149:e98.
    PubMed     Abstract available


  217. HU HY, Yan F, Zhu JM, Karuno AP, et al
    Intercontinental transmission and local demographic expansion of SARS-CoV-2.
    Epidemiol Infect. 2021;149:e94.
    PubMed     Abstract available


  218. MOETI M
    Leadership, collaboration and using data science to fight COVID-19 in the WHO African region.
    Epidemiol Infect. 2021;149:e262.
    PubMed    


  219. SEMENZA JC, Adlhoch C, Baka A, Broberg E, et al
    COVID-19 research priorities for non-pharmaceutical public health and social measures.
    Epidemiol Infect. 2021;149:e87.
    PubMed     Abstract available


  220. MASSAD E, Amaku M, Tadeu Covas D, Fernandes Lopez L, et al
    Estimating the effects of reopening of schools on the course of the epidemic of COVID-19.
    Epidemiol Infect. 2021;149:e86.
    PubMed     Abstract available


  221. MAO Y, Tan YR, Thein TL, Chai YAL, et al
    Identifying COVID-19 cases in outpatient settings.
    Epidemiol Infect. 2021;149:e92.
    PubMed     Abstract available


    March 2021
  222. WANG K, Wang X, Du J, Liu C, et al
    Relationship between changes in the course of COVID-19 and ratio of neutrophils-to-lymphocytes and related parameters in patients with severe vs. common disease.
    Epidemiol Infect. 2021;149:e81.
    PubMed     Abstract available


  223. MUKHERJEE A, Anand T, Agarwal A, Singh H, et al
    SARS-CoV-2 re-infection: development of an epidemiological definition from India.
    Epidemiol Infect. 2021;149:e82.
    PubMed     Abstract available


  224. BLANCO N, Stafford KA, Lavoie MC, Brandenburg A, et al
    A simple model for the total number of SARS-CoV-2 infections on a national level.
    Epidemiol Infect. 2021;149:e80.
    PubMed     Abstract available


  225. GALLO O, Peris A, Trotta M, Orlando P, et al
    Epidemiological analysis of a COVID-19 outbreak associated with an infected surgeon.
    Epidemiol Infect. 2021;149:e77.
    PubMed     Abstract available


  226. OGIMI C, Qu P, Boeckh M, Bender Ignacio RA, et al
    Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis.
    Epidemiol Infect. 2021;149:e75.
    PubMed     Abstract available


  227. KUCHENHOFF H, Gunther F, Hohle M, Bender A, et al
    Analysis of the early COVID-19 epidemic curve in Germany by regression models with change points.
    Epidemiol Infect. 2021;149:e68.
    PubMed     Abstract available


  228. KOZER E, Rinott E, Kozer G, Bar-Haim A, et al
    Presence of SARS-CoV-2 RNA on playground surfaces and water fountains.
    Epidemiol Infect. 2021;149:e67.
    PubMed     Abstract available


  229. ELSON R, Davies TM, Lake IR, Vivancos R, et al
    The spatio-temporal distribution of COVID-19 infection in England between January and June 2020.
    Epidemiol Infect. 2021;149:e73.
    PubMed     Abstract available


  230. TAKEFUJI Y
    Fourier analysis using the number of COVID-19 daily deaths in the US.
    Epidemiol Infect. 2021;149:e64.
    PubMed     Abstract available


  231. BOHM S, Woudenberg T, Chen D, Marosevic DV, et al
    Epidemiology and transmission characteristics of early COVID-19 cases, 20 January-19 March 2020, in Bavaria, Germany.
    Epidemiol Infect. 2021;149:e65.
    PubMed     Abstract available


    February 2021
  232. CASTRO RR, Santos RSC, Sousa GJB, Pinheiro YT, et al
    Spatial dynamics of the COVID-19 pandemic in Brazil.
    Epidemiol Infect. 2021;149:e60.
    PubMed     Abstract available


  233. MICHOS A, Savvidou P, Syridou G, Eleftheriou E, et al
    SARS-CoV-2 molecular testing in Greek hospital paediatric departments: a nationwide study.
    Epidemiol Infect. 2021;149:e70.
    PubMed     Abstract available


  234. CHENG A, Chen Y, Gao Y, Sun P, et al
    Mobile isolation wards in a fever clinic: a novel operation model during the COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e61.
    PubMed     Abstract available


  235. HONG K, Yum SJ, Kim JH, Chun BC, et al
    Re-estimation of basic reproduction number of COVID-19 based on the epidemic curve by symptom onset date.
    Epidemiol Infect. 2021;149:e53.
    PubMed     Abstract available


  236. DUQUE MP, Lucaccioni H, Costa C, Marques R, et al
    COVID-19 symptoms: a case-control study, Portugal, March-April 2020.
    Epidemiol Infect. 2021;149:e54.
    PubMed     Abstract available


  237. LEHMANN J, Giesinger JM, Rumpold G, Borena W, et al
    Estimating seroprevalence of SARS-CoV-2 antibodies using three self-reported symptoms: development of a prediction model based on data from Ischgl, Austria.
    Epidemiol Infect. 2021;149:e52.
    PubMed     Abstract available


  238. ZHAO K, Ai L, Zhao Y, Wang T, et al
    Diagnostic value of using a combination of nucleic acid and specific antibody tests for SARS-CoV-2 in coronavirus disease 2019.
    Epidemiol Infect. 2021;149:e62.
    PubMed     Abstract available


  239. LELIS DA SILVA F, Dias Pita J, Gomes MDA, Lelis da Silva AP, et al
    Intraregional propagation of Covid-19 cases in Para, Brazil: assessment of isolation regime to lockdown.
    Epidemiol Infect. 2021;149:e72.
    PubMed     Abstract available


  240. GAO Y, Chen Y, Liu M, Niu M, et al
    Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis.
    Epidemiol Infect. 2021;149:e66.
    PubMed     Abstract available


  241. MIYAMA T, Iritani N, Nishio T, Ukai T, et al
    Seasonal shift in epidemics of respiratory syncytial virus infection in Japan.
    Epidemiol Infect. 2021;149:e55.
    PubMed     Abstract available


  242. AI J, Shi N, Shi Y, Xu K, et al
    Epidemiologic characteristics and influencing factors of cluster infection of COVID-19 in Jiangsu Province.
    Epidemiol Infect. 2021;149:e48.
    PubMed     Abstract available


  243. SHANG C, Yang Y, Chen GY, Shang XD, et al
    A simple transmission dynamics model for predicting the evolution of COVID-19 under control measures in China.
    Epidemiol Infect. 2021;149:e43.
    PubMed     Abstract available


  244. BAILIE CR, Franklin L, Nicholson S, Mordant F, et al
    Symptoms and laboratory manifestations of mild COVID-19 in a repatriated cruise ship cohort.
    Epidemiol Infect. 2021;149:e44.
    PubMed     Abstract available


  245. WEIBELZAHL S, Reiter J, Duden G
    Depression and anxiety in healthcare professionals during the COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e46.
    PubMed     Abstract available


  246. GEORGE CE, Inbaraj LR, Chandrasingh S, de Witte LP, et al
    High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?
    Epidemiol Infect. 2021;149:e39.
    PubMed     Abstract available


  247. KAMAR A, Maalouf N, Hitti E, El Eid G, et al
    Challenge of forecasting demand of medical resources and supplies during a pandemic: A comparative evaluation of three surge calculators for COVID-19.
    Epidemiol Infect. 2021;149:e51.
    PubMed     Abstract available


  248. SINGH RKS, Malik MZ, Singh RKB
    Diversity of SARS-CoV-2 isolates driven by pressure and health index.
    Epidemiol Infect. 2021;149:e38.
    PubMed     Abstract available


    January 2021
  249. PETT J, McAleavey P, McGurnaghan P, Spiers R, et al
    Epidemiology of COVID-19 in Northern Ireland, 26 February 2020-26 April 2020.
    Epidemiol Infect. 2021;149:e36.
    PubMed     Abstract available


  250. PRANATA R, Lim MA, Yonas E, Huang I, et al
    Thrombocytopenia as a prognostic marker in COVID-19 patients: diagnostic test accuracy meta-analysis.
    Epidemiol Infect. 2021;149:e40.
    PubMed     Abstract available


  251. ZAVASCKI AP
    Urgent need for evaluation of point-of-care tests as an RT-PCR-sparing strategy for the diagnosis of Covid-19 in symptomatic patients.
    Epidemiol Infect. 2021;149:e35.
    PubMed    


  252. CHOW WK, Chow CL
    Response to Letter to Editor by Zavascki A.P.: Urgent need for evaluating point-of-care tests as a RT-PCR-sparing strategy for the diagnosis of Covid-19 in symptomatic patients.
    Epidemiol Infect. 2021;149:e33.
    PubMed    


  253. WANG Y, Luo H, Liu S, Hao T, et al
    Respiratory failure among patients with COVID-19 in Jiangsu province, China: a multicentre retrospective cohort study.
    Epidemiol Infect. 2021;149:e31.
    PubMed     Abstract available


  254. SETHI SM, Ahmed AS, Hanif S, Aqeel M, et al
    Subcutaneous emphysema and pneumomediastinum in patients with COVID-19 disease; case series from a tertiary care hospital in Pakistan.
    Epidemiol Infect. 2021;149:e37.
    PubMed     Abstract available


  255. VENTURELLI S, Benatti SV, Casati M, Binda F, et al
    Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation.
    Epidemiol Infect. 2021;149:e32.
    PubMed     Abstract available


  256. WENG CH, Saal A, McGuire DC, Chan PA, et al
    Persistently high SARS-CoV-2 positivity rate and incidence for Hispanic/Latinos during state reopening in an urban setting: a retrospective cohort study.
    Epidemiol Infect. 2021;149:e25.
    PubMed     Abstract available


  257. LE TD, Bosworth M, Ledlow G, Le TT, et al
    Influences of reopening businesses and social venues: COVID-19 incidence rate in East Texas county.
    Epidemiol Infect. 2021;149:e28.
    PubMed     Abstract available


  258. WEI J, Guo S, Long E, Zhang L, et al
    Why does the spread of COVID-19 vary greatly in different countries? Revealing the efficacy of face masks in epidemic prevention.
    Epidemiol Infect. 2021;149:e24.
    PubMed     Abstract available


  259. ISHIKAWA G, Argenti G, Fadel CB
    Non-specific blood tests as proxies for COVID-19 hospitalisation: are there plausible associations after excluding noisy predictors?
    Epidemiol Infect. 2021;149:e23.
    PubMed     Abstract available


  260. LI W, Gong J, Zhou J, Zhang L, et al
    An evaluation of COVID-19 transmission control in Wenzhou using a modified SEIR model.
    Epidemiol Infect. 2021;149:e2.
    PubMed     Abstract available


  261. GE Y, Sun S, Shen Y
    Estimation of case-fatality rate in COVID-19 patients with hypertension and diabetes mellitus in the New York state: a preliminary report.
    Epidemiol Infect. 2021;149:e14.
    PubMed     Abstract available


  262. SALMON RL, Monaghan SP
    Who is dying from COVID-19 in the United Kingdom? A review of cremation authorisations from a single South Wales' crematorium.
    Epidemiol Infect. 2021;149:e13.
    PubMed     Abstract available


  263. SHARIF N, Dey SK
    Impact of population density and weather on COVID-19 pandemic and SARS-CoV-2 mutation frequency in Bangladesh.
    Epidemiol Infect. 2021;149:e16.
    PubMed     Abstract available


  264. LIU Y, Haussinger L, Steinacker JM, Dinse-Lambracht A, et al
    Association between the dynamics of the COVID-19 epidemic and ABO blood type distribution.
    Epidemiol Infect. 2021;149:e19.
    PubMed     Abstract available


  265. ILESANMI OS, Afolabi AA, Akande A, Raji T, et al
    Infection prevention and control during COVID-19 pandemic: realities from health care workers in a north central state in Nigeria.
    Epidemiol Infect. 2021;149:e15.
    PubMed     Abstract available


  266. WEI ZY, Qiao R, Chen J, Huang J, et al
    The influence of pre-existing hypertension on coronavirus disease 2019 patients.
    Epidemiol Infect. 2021;149:e4.
    PubMed     Abstract available


  267. LIANG C, Shen L
    An analysis of coronavirus disease 2019 with spline regression at province level during first-level response to major public health emergency out of Hubei, China.
    Epidemiol Infect. 2021;149:e10.
    PubMed     Abstract available


  268. CHOW WK, Chow CL
    A discussion on implementing pooling detection tests of novel coronavirus (SARS-CoV-2) for a large population.
    Epidemiol Infect. 2021;149:e17.
    PubMed     Abstract available


  269. DENG L, Zhang J, Wang M, Chen L, et al
    Obesity is associated with severe COVID-19 but not death: a dose-response meta-analysis.
    Epidemiol Infect. 2021;149:e144.
    PubMed     Abstract available


    December 2020
  270. WEI C, Lee CC, Hsu TC, Hsu WT, et al
    Correlation of population mortality of COVID-19 and testing coverage: a comparison among 36 OECD countries.
    Epidemiol Infect. 2020;149:e1.
    PubMed     Abstract available


  271. FERNANDEZ-SALINAS J, Aragon-Caqueo D, Valdes G, Laroze D, et al
    Modelling pool testing for SARS-CoV-2: addressing heterogeneity in populations.
    Epidemiol Infect. 2020;149:e9.
    PubMed     Abstract available


  272. YANG J, Ma Z, Lei Y
    A meta-analysis of the association between obesity and COVID-19.
    Epidemiol Infect. 2020;149:e11.
    PubMed     Abstract available


  273. ARINO J, Bajeux N, Portet S, Watmough J, et al
    Quarantine and the risk of COVID-19 importation.
    Epidemiol Infect. 2020;148:e298.
    PubMed     Abstract available


  274. YUNG CF, Saffari E, Liew C
    Time to Rt < 1 for COVID-19 public health lockdown measures.
    Epidemiol Infect. 2020;148:e301.
    PubMed     Abstract available


  275. YOUNG BE, Mak TM, Ang LW, Sadarangani S, et al
    Influenza vaccine failure in the tropics: a retrospective cohort study of waning effectiveness.
    Epidemiol Infect. 2020 Dec 2:1-29. doi: 10.1017/S0950268820002952.
    PubMed    


  276. DE ALMEIDA GB, Pronunciate M, Grotto RMT, Azevedo Pugliesi E, et al
    Two hundred days of COVID-19 in Sao Paulo State, Brazil.
    Epidemiol Infect. 2020;148:e295.
    PubMed     Abstract available


  277. ANDRADE LA, Gomes DS, Lima SVMA, Duque AM, et al
    COVID-19 mortality in an area of northeast Brazil: epidemiological characteristics and prospective spatiotemporal modelling.
    Epidemiol Infect. 2020;148:e288.
    PubMed     Abstract available


  278. MO P, Deng L, Liu X, Gao S, et al
    Risk factors for delayed negative conversion of SARS-CoV-2 in patients with COVID-19 pneumonia: a retrospective cohort study.
    Epidemiol Infect. 2020;148:e293.
    PubMed     Abstract available


    November 2020
  279. MANCILLA-GALINDO J, Vera-Zertuche JM, Navarro-Cruz AR, Segura-Badilla O, et al
    Development and validation of the patient history COVID-19 (PH-Covid19) scoring system: a multivariable prediction model of death in Mexican patients with COVID-19.
    Epidemiol Infect. 2020;148:e286.
    PubMed     Abstract available


  280. THOMPSON JV, Meghani NJ, Powell BM, Newell I, et al
    Patient characteristics and predictors of mortality in 470 adults admitted to a district general hospital in England with Covid-19.
    Epidemiol Infect. 2020;148:e285.
    PubMed     Abstract available


  281. CAO Y, Wang Y, Das A, Pan CQ, et al
    Transmission dynamics of COVID-19 among index case family clusters in Beijing, China.
    Epidemiol Infect. 2020;149:e74.
    PubMed     Abstract available


  282. HABONIMANA D, Ouedraogo L, Ndirahisha E, Misago N, et al
    Understanding the influence of the COVID-19 pandemic on hospital-based mortality in Burundi: a cross-sectional study comparing two time periods.
    Epidemiol Infect. 2020;148:e280.
    PubMed     Abstract available


  283. SANTAMARIA L, Hortal J
    Chasing the ghost of infection past: identifying thresholds of change during the COVID-19 infection in Spain.
    Epidemiol Infect. 2020;148:e282.
    PubMed     Abstract available


  284. SUNG J, Choudry N, Bachour R
    Development and validation of a simple risk score for diagnosing COVID-19 in the emergency room.
    Epidemiol Infect. 2020;148:e273.
    PubMed     Abstract available


  285. SULYOK M, Walker M
    Community movement and COVID-19: a global study using Google's Community Mobility Reports.
    Epidemiol Infect. 2020;148:e284.
    PubMed     Abstract available


  286. SHAKIBA M, Nazemipour M, Heidarzadeh A, Mansournia MA, et al
    Prevalence of asymptomatic COVID-19 infection using a seroepidemiological survey.
    Epidemiol Infect. 2020;148:e300.
    PubMed     Abstract available


  287. KAZANCIOGLU S, Bastug A, Ozbay BO, Kemirtlek N, et al
    The Role of Hematological Parameters in Patients with Coronavirus Disease 2019 and Influenza Virus Infection.
    Epidemiol Infect. 2020 Nov 5:1-16. doi: 10.1017/S095026882000271.
    PubMed    


  288. GREBE G, Velez JA, Tiutiunnyk A, Aragon-Caqueo D, et al
    Dynamic quarantine: a comparative analysis of the Chilean public health response to COVID-19.
    Epidemiol Infect. 2020;148:e270.
    PubMed     Abstract available


  289. GURSAKAL N, Batmaz B, Aktuna G
    Drawing transmission graphs for COVID-19 in the perspective of network science.
    Epidemiol Infect. 2020;148:e269.
    PubMed     Abstract available


    October 2020
  290. ISLAM MZ, Riaz BK, Islam ANMS, Khanam F, et al
    Risk factors associated with morbidity and mortality outcomes of COVID-19 patients on the 28th day of the disease course: a retrospective cohort study in Bangladesh.
    Epidemiol Infect. 2020;148:e263.
    PubMed     Abstract available


  291. RIVERA R, Rosenbaum JE, Quispe W
    Excess mortality in the United States during the first three months of the COVID-19 pandemic.
    Epidemiol Infect. 2020;148:e264.
    PubMed     Abstract available


  292. MAJUMDAR P, Niyogi S
    ORF3a mutation associated with higher mortality rate in SARS-CoV-2 infection.
    Epidemiol Infect. 2020;148:e262.
    PubMed     Abstract available


  293. MEIKSIN A
    Dynamics of COVID-19 transmission including indirect transmission mechanisms: a mathematical analysis.
    Epidemiol Infect. 2020;148:e257.
    PubMed     Abstract available


  294. ZHANG SX, Graf-Vlachy L, Looi KH, Su R, et al
    Social media use as a predictor of handwashing during a pandemic: evidence from COVID-19 in Malaysia.
    Epidemiol Infect. 2020;148:e261.
    PubMed     Abstract available


  295. ZENG L, Wang S, Cai J, Sun S, et al
    Clinical characteristics of COVID-19 with cardiac injury: a systematic review and meta-analysis.
    Epidemiol Infect. 2020;148:e266.
    PubMed     Abstract available


  296. DE SALAZAR PM, Gomez-Barroso D, Pampaka D, Gil JM, et al
    Lockdown measures and relative changes in the age-specific incidence of SARS-CoV-2 in Spain.
    Epidemiol Infect. 2020;148:e268.
    PubMed     Abstract available


  297. LI X, Marmar T, Xu Q, Tu J, et al
    Predictive indicators of severe COVID-19 independent of comorbidities and advanced age: a nested case-control study.
    Epidemiol Infect. 2020;148:e255.
    PubMed     Abstract available


  298. BRANDL M, Selb R, Seidl-Pillmeier S, Marosevic D, et al
    Mass gathering events and undetected transmission of SARS-CoV-2 in vulnerable populations leading to an outbreak with high case fatality ratio in the district of Tirschenreuth, Germany.
    Epidemiol Infect. 2020;148:e252.
    PubMed     Abstract available


  299. TEIXEIRA R, Doetsch J
    The multifaceted role of mobile technologies as a strategy to combat COVID-19 pandemic.
    Epidemiol Infect. 2020;148:e244.
    PubMed     Abstract available


  300. TAKAYA S, Tsuzuki S, Hayakawa K, Kawashima A, et al
    Nightlife clusters of coronavirus disease in Tokyo between March and April 2020.
    Epidemiol Infect. 2020;148:e250.
    PubMed     Abstract available


  301. GOODALL JW, Reed TAN, Ardissino M, Bassett P, et al
    Risk factors for severe disease in patients admitted with COVID-19 to a hospital in London, England: a retrospective cohort study.
    Epidemiol Infect. 2020;148:e251.
    PubMed     Abstract available


  302. KHAN ZS, Van Bussel F, Hussain F
    A predictive model for Covid-19 spread - with application to eight US states and how to end the pandemic.
    Epidemiol Infect. 2020;148:e249.
    PubMed     Abstract available


  303. SIFF EJ, Aghagoli G, Gallo Marin B, Tobin-Tyler E, et al
    SARS-CoV-2 transmission: a sociological review.
    Epidemiol Infect. 2020;148:e242.
    PubMed     Abstract available


  304. WANG Y, Xu C, Yao S, Zhao Y, et al
    Forecasting the epidemiological trends of COVID-19 prevalence and mortality using the advanced alpha-Sutte Indicator.
    Epidemiol Infect. 2020;148:e236.
    PubMed     Abstract available


  305. GUO J, Zhou B, Zhu M, Yuan Y, et al
    CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study.
    Epidemiol Infect. 2020;148:e241.
    PubMed     Abstract available


    September 2020
  306. SHI P, Ren G, Yang J, Li Z, et al
    Clinical characteristics of imported and second-generation coronavirus disease 2019 (COVID-19) cases in Shaanxi outside Wuhan, China: a multicentre retrospective study.
    Epidemiol Infect. 2020;148:e238.
    PubMed     Abstract available


  307. SINGH D, Joshi K, Samuel A, Patra J, et al
    Alcohol-based hand sanitisers as first line of defence against SARS-CoV-2: a review of biology, chemistry and formulations.
    Epidemiol Infect. 2020;148:e229.
    PubMed     Abstract available


  308. LOPEZ-ABENTE J, Valor-Suarez C, Lopez-Abente G
    Massive application of the SARS-CoV-2 diagnostic test: simulation of its effect on the evolution of the epidemic in Spain.
    Epidemiol Infect. 2020;148:e233.
    PubMed     Abstract available


  309. FERNANDES DE, Ferreira PRA, Mastroianni Kirsztajn G
    Pre-exposure prophylaxis during the SARS-CoV-2 pandemic: can PrEP prevent COVID-19-related symptoms?
    Epidemiol Infect. 2020;148:e231.
    PubMed     Abstract available


  310. GUBENSEK J, Vajdic Trampuz B, Persic V, Gregorcic S, et al
    The possibility of SARS-CoV-2 transmission in a haemodialysis unit - report from a large in-hospital centre.
    Epidemiol Infect. 2020;148:e226.
    PubMed     Abstract available


  311. SARASWATHI S, Mukhopadhyay A, Shah H, Ranganath TS, et al
    Social network analysis of COVID-19 transmission in Karnataka, India.
    Epidemiol Infect. 2020;148:e230.
    PubMed     Abstract available


  312. ZONGO P, Zorom M, Mophou G, Dorville R, et al
    A model of COVID-19 transmission to understand the effectiveness of the containment measures: application to data from France.
    Epidemiol Infect. 2020;148:e221.
    PubMed     Abstract available


  313. CHEEMA S, Ameduri M, Abraham A, Doraiswamy S, et al
    The COVID-19 pandemic: the public health reality.
    Epidemiol Infect. 2020;148:e223.
    PubMed     Abstract available


  314. CHEN M, Wei X, Wang Z
    Protecting healthcare workers from SARS-CoV-2 and other infections.
    Epidemiol Infect. 2020;148:e217.
    PubMed     Abstract available


  315. AHMAD I, Muhammad Asad S
    Predictions of coronavirus COVID-19 distinct cases in Pakistan through an artificial neural network.
    Epidemiol Infect. 2020;148:e222.
    PubMed     Abstract available


  316. CHEN LZ, Lin ZH, Chen J, Liu SS, et al
    Can elevated concentrations of ALT and AST predict the risk of 'recurrence' of COVID-19?
    Epidemiol Infect. 2020;148:e218.
    PubMed     Abstract available


  317. SONG W, Sawafta FJ, Ebrahem BM, Jebril MA, et al
    Public attitude towards quarantine during the COVID-19 outbreak.
    Epidemiol Infect. 2020;148:e220.
    PubMed     Abstract available


  318. DUAN P, Deng ZQ, Pan ZY, Wang YP, et al
    Safety considerations during return to work in the context of stable COVID-19 epidemic control: an analysis of health screening results of all returned staff from a hospital.
    Epidemiol Infect. 2020;148:e214.
    PubMed     Abstract available


  319. HAW NJL, Uy J, Sy KTL, Abrigo MRM, et al
    Epidemiological profile and transmission dynamics of COVID-19 in the Philippines.
    Epidemiol Infect. 2020;148:e204.
    PubMed     Abstract available


  320. TINTO B, Salinas S, Dicko A, Kagone TS, et al
    Spreading of SARS-CoV-2 in West Africa and assessment of risk factors.
    Epidemiol Infect. 2020;148:e213.
    PubMed     Abstract available


  321. ELIMIAN KO, Ochu CL, Ilori E, Oladejo J, et al
    Descriptive epidemiology of coronavirus disease 2019 in Nigeria, 27 February-6 June 2020.
    Epidemiol Infect. 2020;148:e208.
    PubMed     Abstract available


  322. BISWAS RK, Afiaz A, Huq S
    Underreporting COVID-19: the curious case of the Indian subcontinent.
    Epidemiol Infect. 2020;148:e207.
    PubMed     Abstract available


  323. WANG X, Li X, Shang Y, Wang J, et al
    Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre.
    Epidemiol Infect. 2020;148:e211.
    PubMed     Abstract available


  324. HAIDER N, Yavlinsky A, Chang YM, Hasan MN, et al
    The Global Health Security index and Joint External Evaluation score for health preparedness are not correlated with countries' COVID-19 detection response time and mortality outcome.
    Epidemiol Infect. 2020;148:e210.
    PubMed     Abstract available


  325. GAYAWAN E, Awe OO, Oseni BM, Uzochukwu IC, et al
    The spatio-temporal epidemic dynamics of COVID-19 outbreak in Africa.
    Epidemiol Infect. 2020;148:e212.
    PubMed     Abstract available


    August 2020
  326. LAI R, Chen E, Gao W, Cheng C, et al
    Sentinel surveillance strategies for early detection of coronavirus disease in fever clinics: experience from China.
    Epidemiol Infect. 2020;148:e205.
    PubMed     Abstract available


  327. LANARI M, Anderson EJ, Sheridan-Pereira M, Carbonell-Estrany X, et al
    Burden of respiratory syncytial virus hospitalisation among infants born at 32-35 weeks' gestational age in the Northern Hemisphere: pooled analysis of seven studies.
    Epidemiol Infect. 2020;148:e170.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: